Correlation Between Ep Emerging and Biotechnology Fund

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ep Emerging and Biotechnology Fund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ep Emerging and Biotechnology Fund into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ep Emerging Markets and Biotechnology Fund Class, you can compare the effects of market volatilities on Ep Emerging and Biotechnology Fund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ep Emerging with a short position of Biotechnology Fund. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ep Emerging and Biotechnology Fund.

Diversification Opportunities for Ep Emerging and Biotechnology Fund

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between EPASX and Biotechnology is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Ep Emerging Markets and Biotechnology Fund Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Fund Class and Ep Emerging is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ep Emerging Markets are associated (or correlated) with Biotechnology Fund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Fund Class has no effect on the direction of Ep Emerging i.e., Ep Emerging and Biotechnology Fund go up and down completely randomly.

Pair Corralation between Ep Emerging and Biotechnology Fund

Assuming the 90 days horizon Ep Emerging is expected to generate 1.47 times less return on investment than Biotechnology Fund. But when comparing it to its historical volatility, Ep Emerging Markets is 1.34 times less risky than Biotechnology Fund. It trades about 0.03 of its potential returns per unit of risk. Biotechnology Fund Class is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  6,239  in Biotechnology Fund Class on September 14, 2024 and sell it today you would earn a total of  516.00  from holding Biotechnology Fund Class or generate 8.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ep Emerging Markets  vs.  Biotechnology Fund Class

 Performance 
       Timeline  
Ep Emerging Markets 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Ep Emerging Markets are ranked lower than 1 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Ep Emerging is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Biotechnology Fund Class 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Fund Class has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Biotechnology Fund is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Ep Emerging and Biotechnology Fund Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ep Emerging and Biotechnology Fund

The main advantage of trading using opposite Ep Emerging and Biotechnology Fund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ep Emerging position performs unexpectedly, Biotechnology Fund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Fund will offset losses from the drop in Biotechnology Fund's long position.
The idea behind Ep Emerging Markets and Biotechnology Fund Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk